Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- proper noun A taxonomic
genus within thefamily Columbidae .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Claravis.
Examples
-
Species of particular concern are black-fronted piping guan Aburria jacutinga (E), Brazilian merganser Mergus octosetaceus (E), purple-winged ground dove Claravis godefrida (E) and helmeted woodpecker Dryocopus galeatus (V).
-
The drug is manufactured by Roche Pharmaceuticals and is also marketed under the generic names Amnesteem, Claravis, Isotretinoin, and Sotret.
-
Isotretinoin is also sold under the brand names of Accutane, Roaccutane, Amnesteem, Claravis and Sotret.
-
And we had some strong growth in some of the products that we had some pickups on Claravis and the Dex family of products because some competitors went out of the markets on those products.
-
Our non-OC sales in North America totaled a $192 million in the September quarter, an increase of $27 million or 17\% driven by higher sales of our Dex family of products and Claravis principally due to higher market shares as a result of competitors leaving the markets or exiting the markets under those products as well as higher sales of Vitamin D due to higher demand.
-
Our non-OC sales in North America totaled a $192 million in the September quarter, an increase of $27 million or 17\% driven by higher sales of our Dex family of products and Claravis principally due to higher market shares as a result of competitors leaving the markets or exiting the markets under those products as well as higher sales of Vitamin D due to higher demand.
-
And we had some strong growth in some of the products that we had some pickups on Claravis and the Dex family of products because some competitors went out of the markets on those products.
-
And we had some strong growth in some of the products that we had some pickups on Claravis and the Dex family of products because some competitors went out of the markets on those products.
-
Our non-OC sales in North America totaled a $192 million in the September quarter, an increase of $27 million or 17\% driven by higher sales of our Dex family of products and Claravis principally due to higher market shares as a result of competitors leaving the markets or exiting the markets under those products as well as higher sales of Vitamin D due to higher demand.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.